SpringRock funds entrepreneurial teams that are solving important problems in disruptive ways. By partnering with us, you work with an experienced investment team with co-founder experience; seasoned in the undulations a start-up undergoes between its founding and its ultimate success. To accelerate time to market and business growth, we offer entrepreneurs support via our corporate development and recruiting network, technical expertise and strategic relationships.
Focus
SpringRock focuses on digital health, devices, services, oral health, SAAS, consumerization/ecommerce of healthcare, IT, wellness, HIPAA and other innovative companies improving general health. We invest in early to late stage, high growth-potential companies with some demonstrated customer acceptance. We invest $2 million to $5 million in a company. We also invest at the seed/EIR stage of oral health innovation. SpringRock is based in Seattle, Washington, but invests throughout North America.
Team
SpringRock is led by an experienced venture investment team with successful healthcare and technology track records. The Managing Directors, Eric Bell and Kirsten Morbeck, collectively have invested in more than forty venture-backed companies with more than twenty five IPOs and acquisitions including C-SATS (JNJ), Vascular Solutions (VASC), Illumina (ILMN), Rosetta Pharmaceuticals (MRK), Tegic Communications (AOL/NUAN), Aquantive (MSFT), Hemosense (HEM), Sabrix (Thomson), InterNAP (INAP) and Pet’s Choice (VCAI). Their experience includes operating backgrounds as co-founders of venture-backed startups and venture investment backgrounds as venture capitalists with Silicon Valley, corporate and regional-based funds.
Sectors
We invest in early to late stage, high growth-potential companies.
